Mid-term clinical outcomes in cardiac surgery of Jehovah's witnesses

Journal of Cardiovascular Medicine

Volumn 11, Issue 3, 2010, Pages 170-174

  Pompei, Esmeralda ^a   Tursi, Vincenzo ^a   Guzzi, Giorgio ^a   Vendramin, Igor ^a   Ius, Fabio ^a   Muzzi, Rodolfo ^b   Auci, Elisabetta ^b   Badano, Luigi Paolo ^a   Livi, Ugolino ^a  

^a Cardiothoracic Department   (Italy)

^b AO Melegnano   (Italy)

Author keywords

Bloodless surgery; Cardiac surgery; Jehovah's witnesses

Indexed keywords

ERYTHROPOIETIN;

ADULT; AGED; AORTA VALVE REPLACEMENT; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; DISEASE CLASSIFICATION; EXTRACORPOREAL CIRCULATION; FEMALE; FOREIGN BODY; HEART SURGERY; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTENSIVE CARE; JEHOVAH'S WITNESS; MALE; MITRAL VALVE REPLACEMENT; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; REOPERATION; SURVIVAL; TREATMENT OUTCOME; VALVULOPLASTY;

AGED; AGED, 80 AND OVER; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; ERYTHROPOIETIN; FEMALE; HEMATINICS; HEMATOCRIT; HEMOGLOBINS; HEMOSTASIS, SURGICAL; HUMANS; INTENSIVE CARE; ITALY; JEHOVAH'S WITNESSES; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RELIGION AND MEDICINE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 76449087592     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283330752     Document Type: Article

References (46)

1. Cooley DA, Crawfoed FS, Howell JF, Beall AC Jr. Open heart surgery in Jehovah's witnesses. Am J Cardiol 1964; 13:779-781.
2. Ott A, Cooley DA. Cardiovascular surgery in Jehovah's witnesses: report of 542 operations without blood transfusion. J Am Med Assoc 1977; 238:1256-1258.
3. Sacks DA, Koppes RH. Blood transfusion and the Jehovah's witnesses: medical and legal issues in obstetrics and gynaecology. Am J Obstet Gynecol 1986; 154:483-486.
4. Doyle D. Blood transfusion and the Jehovah's witness patient. Am J Ther 2002; 9:417-424.
5. Muramoto O. Bioethical aspects of the recent changes in the policy of refusal of blood by Jehovah's witnesses. BMJ 2001; 322:37-39.
6. The Royal College of Surgeons of England. Code of practice for the surgical management of Jehovah's Witnesses. London: RCSE; 1996.
7. The Association of Anaesthetists of Great Britain and Ireland. Management of Anaesthesia for Jehovah's witnesses. London: The Association of Anaesthetists of Great Britain and Ireland; 1999.
8. Marsh JC, Bevan DH. Haematological care of the Jehovah's witness patient. Br J Haematol 2002; 119:25-37.
9. Loubser PG, Stoltz SM, Schmoker JD, Bonifacio F, Battle RW, Marcus S, et al. Blood conservation strategies in Jehovah's witness patients undergoing complex aortic surgery: a report of three cases. J Cardiothor Vasc Anesth 2003; 17:528-535.
10. de Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M, Young DC. Baseline hemoglobin as a predictor of risk of transfusion and response to epoietin alfa in orthopedic surgery patients. Am J Orthop 1996; 25:533-542.
11. Henry DA, Henderson KM, Fryer JL, Treloar CJ, McGrath KM, Deveridge SF. Use of interventions to minimize perioperative allogenic blood transfusion in Australia. Med J Aust 2000; 172:365-369.
12. Fergusson D, Blair A, Henry D, Hisashige A, Huet C, Koopman-van Gemert A, et al. Technologies to minimize blood transfusion in cardiac and orthopedic surgery: results of a practice variation survey in nine countries. International Study of Peri-operative Transfusion (ISPOT) Investigators. Int J Technol Assess Healthcare 1999; 15:717-728.
13. McGill N,O'Shaughnessy D, Pickering R, Herbertson M, Gill R. Mechanical methods of reducing blood transfusion in cardiac surgery: randomized controlled trial. BMJ 2002; 324:1299-1305.
14. Reyes G, Nuche JM, Sarraj A, Cobiella J, Orts M, Martin G, et al. Bloodless cardiac surgery in Jehovah's witnesses: outcomes compared with a control group. Rev Esp Cardiol 2007; 60:727-731.
15. Gohel MS, Bulbulia RA, Slim FJ, Poskitt KR, Whyman MR. How to approach major surgery where patients refuse blood transfusion (including Jehovah's witnesses). Ann R Coll Surg Engl 2005; 87:3-14.
16. Boldt J, Weber A, Mailer K, Papsdorf M, Schuster P. Acute normovolaemic haemodiluition vs. controlled hypotension for reducing the use of allogenic blood in patients undergoing radical prostatectomy. Br J Anaesth 1999; 82:170-174.
17. Pasic M, Ruisz W, Koster A, Hetzer R. Bloodless surgery of acute type A aortic dissection in a Jehovah's witness patient. Ann Thorac Surg 2005; 80:1507-1510.
18. Helm RE, Rosengart TK, Gomez M, Klemperer JD, DeBois WJ, Velasco F, et al. Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion. Ann Thorac Surg 1998; 65:125-136.
19. Martyn V, Farmer SL, Wren MN, Towler SC, Betta J, Shander A, et al. The theory and practice of bloodless surgery. Transfus Apheresis Sci 2002; 27:29-43.
20. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briët E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995; 333:11-17.
21. Holt RL, Martin TD, Hess PJ, Beaver TM, Klodell CT. Jehovah's witnesses requiring complex urgent cardiothoracic surgery. Ann Thorac Surg 2004; 78:695-697.
22. Lewis CT, Murphy MC, Cooley DA. Risk factors for cardiac operations in adult Jehovah witnesses. Ann Thorac Surg 1991; 51:448-450.
23. Cuenca JJ, Herrera JM, Rodríguez-Delgadillo MA, Paladini G, Campos V, Rodríguez F, et al. Revascularizaciò n miocardica arterial completa con ambas arterias mamarias sin circulation extracorporeal. Rev Esp Cardiol 2000; 53:632-641.
24. Just SS, Muller T, Albes JM. Minimized closed circuit/centrifugal pump extracorporeal circulation: an effective aid in coronary bypass operations in Jehovah's witnesses. Interact Cardiovasc Thorac Surg 2007; 6:124-125.
25. Just SS, Muller T, Hartrumpf M, Albes JM. First experience with closed circuit/centrifugal pump extracorporeal circulation: cellular trauma, coagulatory, and inflammatory response. Interact Cardiovasc Thorac Surg 2006; 5:646-648.
26. Cheung EH, Sutton SW, Marcel R. Aortic valve replacement in a dialysisdependent Jehovah's witness: successful use of a minicircuit, microplegia, and multimodality blood conservation technique. Proc (Bayl Univ Med Cent) 2007; 20:32-35.
27. Williams M, Blocksom JM, Baciewicz FA. Coronary artery bypass grafting in a dialysis-dependent Jehovah's witness. Tex Heart Inst J 2004; 31:181-183.
28. Burnett CM, Duncan JM, Vega JD, Lonquist JL, Sweeney MS, Frazier OH. Heart transplantation in Jehovah's witnesses. An initial experience and follow-up. Arch Surg 1990; 125:1430-1433.
29. Chikada M, Furuse A, Kotsuka Y, Yagyu K. Open heart surgery in Jehovah's witness patients. Cardiovasc Surg 1996; 4:311-314.
30. Estioko MR, Litwak RS, Rand JH. Reoperation, emergency and urgent open cardiac surgery in Jehovah's witnesses. Chest 1992; 102:50-53.
31. Sarac TP, Clifford C, Waters J, Clair DG, Ouriel K. Preoperative erythropoietin and blood conservation management for thoracoabdominal aneurysm repair in Jehovah's witness. J Vasc Surg 2003; 37:453-455.
32. Casati V, D'Angelo A, Barbato L, Turolla D, Villa F, Grasso MA, et al. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogenic transfusions. J Thorac Cardiovasc Surg 2000; 120:520-527.
33. Casati V, D'Angelo A, Barbato L, Turolla D, Villa F, Grasso MA, et al. Perioperative management of four anaemic female Jehovah's witnesses undergoing urgent complex cardiac surgery. Br J Anaesth 2007; 99:349-352.
34. Madjdpour C, Spahn DR. Allogenic red blood cell transfusion: efficacy, risks, alternatives and indications. Br J Anaesth 2005; 95:33-42.
35. Renton MC, McClelland DB, Sinclair CJ. Use of blood products in cardiac surgery. Perfusion 1997; 3:157-162.
36. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, et al. Anemia and blood transfusion in critically ill patients. J Am Med Assoc 2002; 288:1499-1507.
37. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusiontransmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334:1685-1690.
38. Duffy G, Neal KR. Differences in postoperative infection rates between patients receiving autologous and allogenic blood transfusion: a metaanalysis of published randomized and non randomized studies. Transfus Med 1996; 6:325-328.
39. Spiess BD, Ley C, Body SC, Siegel LC, Stover EP, Maddi R, et al. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Thorac Cardiovasc Surg 1998; 116:460-467.
40. Vamvakas EC. Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials. Transfusion 1996; 36:175-186.
41. Agarwal N, Murphy JG, Cayten CG, Stahl WM. Blood transfusion increases the risk of infection after trauma. Arch Surg 1993; 128:171-176.
42. Carson JL, Altman DG, Duff A, Noveck H, Weinstein MP, Sonnenberg FA. Risk of bacterial infection associated with allogenic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999; 39:694-700.
43. Blumberg N, Heal JM. Blood transfusion immunomodulation: the silent epidemic. Arch Pathol Lab Med 1998; 122:117-119.
44. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts-blood transfusion. N Engl J Med 1999; 340:438-447.
45. Klein HG. Immunomodulatory aspects of transfusion: a once and future risk? Anesthesiology 1999; 91:861-865.
46. Popovsky MA, Davenport RD. Transfusion-related acute lung injury: femme fatale? Transfusion 2001; 41:312-315.